MedTrace Logo

The Study of Wuling Capsule in Treatment Chronic Tinnitus

NCT03674853 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2022-07-25

No results posted yet for this study

Summary

To evaluate the effect of psychological/mental factors on the severity of subjective tinnitus, to observe the efficacy and safety of Wuling capsule in the treatment of chronic subjective tinnitus with emotional disorders, and to evaluate the control rate of tinnitus complications, such as depression, anxiety and insomnia, and the improvement of patients'quality of life.

Conditions

  • Tinnitus, Subjective

Interventions

DRUG

Wuling Capsule

take Wuling Capsule in experiment group for 2 months

DRUG

Oryzanol

take oryzanol in active comparator group for 2 months

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Zha Dingjun, doctor · First Affiliated Hospital of Fourth Military Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-12
Primary Completion
2019-10-30
Completion
2020-03-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03674853 on ClinicalTrials.gov